Brian J. Bolwell

11.3k total citations · 2 hit papers
256 papers, 5.8k citations indexed

About

Brian J. Bolwell is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Brian J. Bolwell has authored 256 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Hematology, 81 papers in Oncology and 58 papers in Pathology and Forensic Medicine. Recurrent topics in Brian J. Bolwell's work include Hematopoietic Stem Cell Transplantation (120 papers), Lymphoma Diagnosis and Treatment (52 papers) and Acute Myeloid Leukemia Research (47 papers). Brian J. Bolwell is often cited by papers focused on Hematopoietic Stem Cell Transplantation (120 papers), Lymphoma Diagnosis and Treatment (52 papers) and Acute Myeloid Leukemia Research (47 papers). Brian J. Bolwell collaborates with scholars based in United States, Canada and United Kingdom. Brian J. Bolwell's co-authors include Ronald Sobecks, Brad Pohlman, Lisa Rybicki, M Kalaycio, Mary M. Horowitz, Patrick J. Stiff, Robert M. Dean, Richard T. Maziarz, Matt Kalaycio and Auayporn Nademanee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Brian J. Bolwell

250 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

2009 512 citations John F. DiPersio, Ivana N. Micallef et al. Journal of Clinical Oncology profile →
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

2011 443 citations Navneet S. Majhail, Mary M. Horowitz et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Brian J. Bolwell

Since Specialization

Citations

This map shows the geographic impact of Brian J. Bolwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Bolwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Bolwell more than expected).

Fields of papers citing papers by Brian J. Bolwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian J. Bolwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Bolwell. The network helps show where Brian J. Bolwell may publish in the future.

Co-authorship network of co-authors of Brian J. Bolwell

This figure shows the co-authorship network connecting the top 25 collaborators of Brian J. Bolwell. A scholar is included among the top collaborators of Brian J. Bolwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian J. Bolwell. Brian J. Bolwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders 2024 ·Leukemia ·Hussein Awada, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Teodora Kuzmanovic, Hassan Awada, Zheng Jin Tu, James R. Cook, Brian J. Bolwell, Ronald Sobecks, Matt Kalaycio, David Bosler, Jaroslaw P. Maciejewski	5
2	Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study 2020 ·UNC Libraries ·Brandon Hayes‐Lattin, (unknown), Michael Linenberger, Galen E. Switzer, Mark R. Litzow, Dennis L. Confer, (unknown), Brian J. Bolwell, Marcie Riches, Rebecca Drexler, Mary M. Horowitz, Roberta King, Bronwen E. Shaw, (unknown), (unknown), Michael A. Pulsipher, Scott D. Rowley	1
3	Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation 2019 ·Hematology/Oncology and Stem Cell Therapy ·Sagar S. Patel, Lisa Rybicki, (unknown), Dawn Thomas, Hien Liu, Robert M. Dean, Deepa Jagadeesh, Brian T. Hill, Brad Pohlman, Brian J. Bolwell, Rabi Hanna, Betty K. Hamilton, Matt Kalaycio, Aaron T. Gerds, Eric Cober, Sherif B. Mossad, Aiwen Zhang, Navneet S. Majhail, Medhat Askar, Ronald Sobecks	6
4	Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome 2019 ·Hematology/Oncology and Stem Cell Therapy ·Sagar S. Patel, Lisa Rybicki, Brad Pohlman, Brian J. Bolwell, Aaron T. Gerds, Betty K. Hamilton, Rabi Hanna, Matt Kalaycio, Navneet S. Majhail, Ronald Sobecks	8
5	Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Brian T. Hill, Lisa Rybicki, Theresa Urban, (unknown), Deepa Jagadeesh, Aaron T. Gerds, Robert M. Dean, Ronald Sobecks, Brad Pohlman, Brian J. Bolwell, Matt Kalaycio, Betty K. Hamilton, Edward A. Copelan, Navneet S. Majhail	9
6	Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days 2017 ·Journal of Clinical Apheresis ·Jack Khouri, Lisa Rybicki, Navneet S. Majhail, Matt Kalaycio, Edward A. Copelan, Brad Pohlman, Brian T. Hill, Robert M. Dean, Aleksandr Lazaryan, Betty K. Hamilton, Steven Andrèsen, Ronald Sobecks, Brian J. Bolwell, Hien Liu	6
7	Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT) 2017 ·Blood ·(unknown), Lisa Rybicki, Brian J. Bolwell, Mohamed A. Kharfan‐Dabaja, Robert M. Dean, Betty K. Hamilton, Rabi Hanna, Deepa Jagadeesh, Matt Kalaycio, Hien Liu, Brad Pohlman, Ronald Sobecks, Brian T. Hill, Navneet S. Majhail	1
8	Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Yazeed Sawalha, Brian T. Hill, Lisa Rybicki, Danyu Sun, Robert M. Dean, Deepa Jagadeesh, Betty K. Hamilton, Aaron T. Gerds, Ronald Sobecks, Steven Andrèsen, (unknown), Navneet S. Majhail, Brad Pohlman, Matt Kalaycio, Brian J. Bolwell, Mitchell R. Smith	5
9	Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study 2016 ·Biology of Blood and Marrow Transplantation ·Galen E. Switzer, (unknown), (unknown), (unknown), Rebecca Drexler, (unknown), Dennis L. Confer, Mary M. Horowitz, Roberta King, Bronwen E. Shaw, Marcie Riches, Brandon Hayes‐Lattin, Michael Linenberger, Brian J. Bolwell, Scott D. Rowley, Mark R. Litzow, Michael A. Pulsipher	8
10	Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer 2015 ·Hematology/Oncology and Stem Cell Therapy ·Betty K. Hamilton, Lisa Rybicki, (unknown), Steven Andrèsen, Matt Kalaycio, Ronald Sobecks, Brad Pohlman, Rabi Hanna, Robert M. Dean, Hien Liu, Brian T. Hill, Brian J. Bolwell, Edward A. Copelan	2
11	Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients 2015 ·Bone Marrow Transplantation ·Betty K. Hamilton, Arjun Law, Lisa Rybicki, (unknown), Jane Dabney, Robert M. Dean, Hien K. Duong, Aaron T. Gerds, Rabi Hanna, Brian T. Hill, Deepa Jagadeesh, M Kalaycio, C. Lawrence, Linda McLellan, Brad Pohlman, Ronald Sobecks, Brian J. Bolwell, Navneet S. Majhail	25
12	Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation 2014 ·Bone Marrow Transplantation ·(unknown), Lisa Rybicki, Sherif B. Mossad, Robin K. Avery, (unknown), Brad Pohlman, Hien Duong, Robert M. Dean, Brenna J. Hill, S Andresen, Rabi Hanna, Navneet S. Majhail, Edward A. Copelan, Brian J. Bolwell, M Kalaycio, Ronald Sobecks	44
13	Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma breakdown → 2009 ·Journal of Clinical Oncology ·John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz, Eric D. Jacobsen, Auayporn Nademanee, John M. McCarty, Gary Bridger, Gary Calandra	512
14	Elevated Ferritin Is Associated with Relapse after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma 2008 ·Biology of Blood and Marrow Transplantation ·Anuj Mahindra, Brian J. Bolwell, Ronald Sobecks, Lisa Rybicki, Brad Pohlman, Robert M. Dean, Steve Andresen, John Sweetenham, Matt Kalaycio, Edward A. Copelan	36
15	Allogeneic hematopoietic cell transplantation for metastatic breast cancer 2007 ·Bone Marrow Transplantation ·Naoto T. Ueno, J. Douglas Rizzo, Taner Demirer, Yee Chung Cheng, Ute Hegenbart, M-J Zhang, Marco Bregni, Angelo Michele Carella, Didier Blaise, Asad Bashey, Jacob D. Bitran, Brian J. Bolwell, Gerald J. Elfenbein, (unknown), César O. Freytes, Robert Peter Gale, Hillard M. Lazarus, Richard E. Champlin, Patrick J. Stiff, Dietger Niederwieser	47
16	Efficient identification of T‐cell clones associated with graft‐versus‐host disease in target tissue allows for subsequent detection in peripheral blood 2005 ·British Journal of Haematology ·Rose Beck, Marcin W. Włodarski, Lukasz P. Gondek, Karl S. Theil, Ralph J. Tuthill, (unknown), Brian J. Bolwell, Jaroslaw P. Maciejewski	21
17	Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone 2003 ·Bone Marrow Transplantation ·Brian J. Bolwell, Ronald Sobecks, Brad Pohlman, Steve Andresen, Karl S. Theil, (unknown), Lisa Rybicki, M Kalaycio	6
18	Routine Cultures of Bone Marrow and Peripheral Stem Cell Harvests: Clinical Impact, Cost Analysis, and Review 1998 ·Clinical Infectious Diseases ·(unknown), Ihab Hajjar, Linda M. Sandhaus, Geraldine S. Hall, Robin K. Avery, Brian J. Bolwell, David L. Longworth, Karim A. Adal	23
19	A randomized study of multi-day infusion of autologous peripheral blood progenitor cells 1998 ·Bone Marrow Transplantation ·Hikmat Abdel‐Razeq, Brad Pohlman, S Andresen, M Kalaycio, Beth Overmoyer, Kimberly Wise, (unknown), (unknown), Marlene Goormastic, Brian J. Bolwell	4
20	The Use of Amplified Variable Number of Tandem Repeats (VNTR) in the Detection of Chimerism Following Bone Marrow Transplantation: A Comparison With Restriction Fragment Length Polymorphism (RFLP) by Southern Blotting 1997 ·American Journal of Clinical Pathology ·Joseph J. Sreenan, James Pettay, Abdelghani Tbakhi, (unknown), Linda M. Sandhaus, Michael L. Miller, Brian J. Bolwell, Raymond R. Tubbs	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact